These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6233439)
1. Comparative effects of nicorandil and nitroglycerin on tracheal and vascular smooth muscle in the dog, in vivo and in vitro. Nakamura Y; Shiraki Y; Nabata H; Sakai K Jpn J Pharmacol; 1984 Mar; 34(3):269-76. PubMed ID: 6233439 [TBL] [Abstract][Full Text] [Related]
2. Comparative vasorelaxing profiles of nicorandil, isosorbide dinitrate and nitroglycerin in isolated coronary arteries of the dog. Ohba Y; Shiraki Y; Sakai K Jpn J Pharmacol; 1987 Nov; 45(3):397-404. PubMed ID: 2963927 [TBL] [Abstract][Full Text] [Related]
3. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs. Kuromaru O; Sakai K Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042 [TBL] [Abstract][Full Text] [Related]
5. Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity. Henry PJ; Horowitz JD; Louis WJ J Cardiovasc Pharmacol; 1990 Mar; 15(3):365-70. PubMed ID: 1691358 [TBL] [Abstract][Full Text] [Related]
6. Effects of nicorandil on the conductive coronary artery of the dog. Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415 [TBL] [Abstract][Full Text] [Related]
7. Relaxing effect of nicorandil (N-2-(hydroxyethyl)-nicotinamide nitrate), a new anti-angina agent, on the isolated vascular smooth muscle. Shibata S; Satake N; Takagi T; Kerfoot F; Suh TK Eur J Pharmacol; 1984 Mar; 99(2-3):219-26. PubMed ID: 6234181 [TBL] [Abstract][Full Text] [Related]
8. Effects of nicorandil and its congeners on musculature and vasculature of the dog trachea in situ. Maruyama M; Satoh K; Taira N Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):260-6. PubMed ID: 6215905 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors. Matsumoto T; Takahashi M; Omura T; Takaoka A; Liu Q; Nakae I; Kinoshita M J Cardiovasc Pharmacol; 1997 Jun; 29(6):772-9. PubMed ID: 9234658 [TBL] [Abstract][Full Text] [Related]
10. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries. Satoh K; Yamada H; Taira N Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660 [TBL] [Abstract][Full Text] [Related]
11. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin. Borg C; Mondot S; Mestre M; Cavero I J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478 [TBL] [Abstract][Full Text] [Related]
12. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil. Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221 [TBL] [Abstract][Full Text] [Related]
13. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery. Zhou Q; Satake N; Shibata S Eur J Pharmacol; 1995 Jan; 273(1-2):153-9. PubMed ID: 7737309 [TBL] [Abstract][Full Text] [Related]
14. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs. Sakai K; Kuromaru O J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420 [TBL] [Abstract][Full Text] [Related]
15. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes. Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563 [TBL] [Abstract][Full Text] [Related]
16. Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim. Noguchi K; Matsuzaki T; Ojiri Y; Koyama T; Nakasone J; Sakanashi M Fundam Clin Pharmacol; 1998; 12(3):270-8. PubMed ID: 9646059 [TBL] [Abstract][Full Text] [Related]
17. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters. Greenberg SS; Cantor E; Ho E; Walega M J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847 [TBL] [Abstract][Full Text] [Related]
18. Dilator effects of nicorandil on isolated perfused coronary arteries of humans. Sakaino N; Araki H; Nishi K Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog. Preuss KC; Gross GJ; Brooks HL; Warltier DC J Cardiovasc Pharmacol; 1985; 7(4):709-14. PubMed ID: 2410712 [TBL] [Abstract][Full Text] [Related]